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Protein structure similarity clustering (PSSC) [1]– [3] is one of a number of potential guiding principles [4], [5] 
that have been introduced to focus combinatorial-library de-
sign/protein targeting. PSSC clusters protein targets with sim-
ilar ligand-binding cores in which little sequence or functional 
similarity is evident. Lead compounds for one member of the 
cluster then provide novel starting points in chemical space 
for ligand development for other members of the PSSC.
We describe herein a new clustering procedure that lends 
itself to ligand docking, molecular dynamics (MD), and the 
vector-alignment-search-tool (VAST) [6] algorithm. This MD-
assisted approach offers an alternative to the serial structure re-
trieval/inspection steps used to generate the original protein 
structure similarity cluster, centered on Cdc25A. [2] Further-
more, in a particularly diffi cult de novo test, the mannose 6-
phosphate/insulin-like growth factor II receptor (M6P/IGF2R), 
lends itself to clustering, with MD opening up connections to 
partners that the static crystal structure coordinates fail to fi nd.
Ortholand and Ganesan [7] have described the disap-
pointing early yield of clinical candidates from combinatorial 
chemistry/high-throughput screening as a paradise lost  sen-
timent, probably attributable to unreasonable expectations and 
the need for maturation in approaches to combinatorial library 
design. [8] Both diversity-oriented synthesis (DOS) and biol-
ogy-oriented synthesis (BIOS) have arisen in response to the 
this need. DOS utilizes more-complex, often fused polycyclic 
frameworks, richer in stereochemistry and frequently func-
tionalizes them through annulation or coupling reactions. [9] 
Within BIOS, [10] biological relevance and prevalidation are 
employed as key arguments for the design of natural-product-
derived/inspired [3], [11] compound collections.
PSSC seeks to add value to such compound libraries by 
grouping targets into otherwise unrecognized clusters. In this 
way, a BIOS library, originally directed at enzymes of a spe-
cifi c functional or homology family, can be redirected at a 
PSSC partner protein and produce novel leads for this target. 
PSSC groups proteins based on a comparison of extracted “li-
gand-sensing cores,” are independent of sequence or function-
al similarity. Importantly, core extraction is independent of 
domain or fold constraints and involves carving out a sphere 
around a key ligand or protein-based center in the binding 
pocket. This approach is complementary to a number of in-
teresting, surface pattern recognition methods that compare 
binding pockets based upon exposed protein surface pseudo-
centers (CavBase, [12] SiteEngine [13]), triangles (pvSOAR), 
[14] cavities, [15] or residues (efSite, [16] PINTS [17]), and 
to the all atom approach exemplifi ed by SitesBase. [18]
The PSSC approach begins in biological space and seeks 
to fi rst identify a cluster of targets of pharmaceutical or bio-
organic interest and then looks for an appropriate lead scaf-
fold, drawing from binding data for one member of the clus-
ter. The notion of a PSS cluster is related to the concept ad-
vanced by Sternberg and co-workers of “supersites,” refl ect-
ing binding-site similarity in the absence of homology. [19] 
PSSC also resonates with interesting ideas put forth by Quinn 
and co-workers, [20] suggesting that structural motifs used to 
bind intermediates in enzymes along a biosynthetic pathway 
for a natural product might also be used to fi nd (unrelated) tar-
get proteins for that same natural product.
The original identifi cation of a PSS cluster [2] began from 
the single available X-ray crystal structure (1C25) [21] for the 
catalytic core of Cdc25A, a dual-specifi city protein phosphatase 
(Figure 1). The Cdc isozymes may represent novel chemother-
apeutic targets. [22] Initial structure similarity searches by us-
ing the combinatorial extension (CE) [23] and Dali-FSSP (fam-
ilies of structurally similar proteins) [24] algorithms connected 
Cdc25A with hydroxynitrile lyase (3YAS) [25] and methylene 
methanopterin dehydrogenase (1LU9), [26] respectively.
These initial cluster members indicated that the parent 
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dual-specifi city phosphatase could be related to proteins ca-
pable of promoting nucleophilic addition to carbonyl centers 
(perhaps presaging carboxyl esterase activity) and with nic-
otinamide-dependent dehydrogenase activity. Koch and co-
workers next used SCOP (structural classifi cation of proteins; 
scop@mrc-lmb.cam.ac.uk), a database from the MRC (The 
Medical Research Council, Cabridge, UK) that groups evolu-
tionarily proteins based on conserved structural elements. [2], 
[27] In this way, beginning from the 3YAS lead, structurally 
related proteins could be located, retrieved, DaliLite [4] or CE 
pairwise-aligned, and examined by visual inspection (Figure 
1). This pathway led to acetylcholinesterase (AChE) as a PSS 
partner for Cdc25A (see Table 1). 
[a] Representative conformers at 100-ps intervals in the MD 
simulation on the Cdc25A-dysidiolide docked structure. [b] 
Results of a DaliLite pairwise comparison with the 1H22 ace-
tylcholinesterase crystal structure. [c] Results of a DaliLite 
pairwise comparison with the 11β-hydroxysteroid dehydroge-
nase structure 1XSE, molecule A in the unit cell. [d] Data in 
bold highlights the time region in which the simulation sam-
ples Cdc25A conformations that align especially well with 
these cluster partners.
A second iteration of this sequence was then carried out. 
This time, the Dali structural alignment identifi ed tropinone 
reductase as an AChE partner. The idea that pyridine nucleo-
tide-based dehydrogenases (DHs) might be in this PSSC had 
been foreshadowed by the initial 1LU9 hit. Indeed, manual in-
spection of the Rossmann fold superfamily, analogous to the 
earlier SCOP step, then led from tropinone reductase to 11β-
hydroxysteroid dehydrogenase (11β-HSDH). Eventually, a 
147-member library based on the sesterterpene Cdc25A inhib-
itor, dysidiolide, [28] also produced inhibitors for both AChE 
and 11 -HSDH (see the Supporting Information). [2]
Motivated by the success of this de novo application of 
PSSC to generate a target cluster that responds to a natural-
product-inspired combinatorial library, we set out to examine 
the clustering protocol more closely. Namely, the initial for-
mulation of this PSSC required two labor-intensive SCOP/su-
perfamily searching steps (Figure 1). This meant the serial re-
trieval of a good number of PDB coordinate sets for cluster 
candidates and their evaluation for active-site structural ho-
mology with the catalytic core of Cdc25A. This was neces-
sitated because available web-based structural comparison al-
gorithms, including CE, [23] Dali, [24] and VAST, [6] all fail 
to fi nd either AChE or 11β-HSDH as structural homologues 
when starting from 1C25, the only available structure for Cd-
c25A.
Given that such structure-comparison algorithms are usu-
ally limited to searching a static set of crystallographic coor-
dinates in the PDB, we wondered whether introducing dynam-
ics [29] would facilitate the structure-homology search. The 
notion is simply that the crystallographic snapshot of a protein 
that is deposited in the PDB is likely to be one of a number of 
conformations that an approaching ligand might encounter in 
solution. If one could begin from an array of conformations 
that Cdc25A likely samples in protein structure space, then a 
structural comparison might be able to identify PSSC partners 
that would not otherwise appear.
Toward this end, (–)-dysidiolide was initially docked with 
the 1C25 structure by using Autodock 3.0. [30] Then, a one-
nanosecond MD simulation was carried out on the docked 
structure (Gromacs [31], Figure 2), collecting snapshots ev-
ery picosecond. To analyze the variations in backbone confor-
Figure 1. The pathway taken by Koch [2] to establish the 
original PSS cluster. Note the use of SCOP and intuition/man-
ual inspection
Figure 2. Cluster distribution of the 1000 conformers result-
ing from the MD simulation (Gromacs) on the dysidiolide-
docked Cdc25A structure shown in Figure 3. All clusters with 
more than 10 members are shown as a function of the time 
of appearance of the midpoint conformer. Circle diameters 
are proportional to cluster size. The midpoint conformer of 
the black-shaded cluster is shown in Figure 3.
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mation with time, along the simulation, pairwise comparisons 
with the structures of AChE (1H22) [32] and of (11β-HSDH-1 
(1XSE-A) [33] were performed at 100-ps intervals (see Table 
1 for results). In particular, one notices that in the 600–700-ps 
regime, the conformations of Cdc25A being sampled appar-
ently show greater structural homology with these two PSSC 
partner proteins. 
The 1000 Cdc25A conformations sampled were clustered 
by using Gromos [31] (Figure 2). Of a total of 60 conforma-
tional clusters found, 26 have more than 10 members. The 
three most populated clusters only begin to appear near the 
midpoint, probably refl ecting a large conformational change 
associated with “fl ap closure” dominating the initial part of 
the simulation. This motion is quite apparent from an anima-
tion of the MD simulation (see the Supporting Information) 
and can be inferred from a comparison of early and late snap-
shots (Figure 3). 
The midpoint conformers of each of the top ten clusters 
were arbitrarily sampled for their ability to fi nd members of the 
original PSS cluster (Figure 1). By using the VAST algorithm, 
all 10 midpoint conformers fi nd hydroxynitrile lyase (HNL) and 
four fi nd methylene tetrahydromethanopterin DH (MTHMP 
DH), which were the only two PSS partners that were initial-
ly identifi able from the static 1C25 structure. Pleasingly, how-
ever, a VAST search initiated from conformer 668 (midpoint of 
the cluster shaded black in Figure 2) fi nds all fi ve members of 
the Cdc25A cluster. More specifi cally, this conformer hits a sig-
nifi cant fraction of the available structures for these proteins in 
the PDB: HNL (22/23), MTHMP DH (2/2), tropinone reductase 
(3/6), AChE (14/66), and 11 -HSDH (1/6).
VAST fi nds good alignment of conformer 668 with 11β-
HSDH-1(1XEA) in the following regions (residues 37–56, 
63–66, 69–77, 91–98, 100–112, and 124–133). If one follows 
the average root mean square deviation (RMSD) for C  atoms 
across these residues, relative to their position in the starting 
conformer, there is a sharp increase from approximately 0.7–1 
Å in the time regime of 600–800 ps. Consistent with this, the 
conformer at 700 ps also fi nds four of the fi ve cluster mem-
bers (see the Supporting Information). A structural overlay of 
conformer 668 with AChE and 11β-HSDH-1 is presented in 
Figure 3 (bottom).
In light of the success of MD to open up new structural 
alignments with VAST, we next set our sights on a de novo test 
of the protocol. In this regard, a particularly diffi cult case was 
chosen; namely, the cation-independent, M6P-IGF2R (see Fig-
ure 4). [34] This large 300-kDa transmembrane receptor con-
tains 15 homologous extracytoplasmic repeats. Domains 3 and 
9 are known to have a high affi nity for M6P. The receptor binds 
M6P-functionalized proteins and IGF-II independently (domain 
11). In addition to serving a range of housekeeping functions 
associated primarily with channeling proteins to the lysosomes, 
the receptor is known to internalize circulating IGF-II and hence 
has been labeled a cancer-suppressor gene. [35] Internalization 
appears to be accelerated by M6P-type ligand binding, [36] in-
creasing interest in high-affi nity ligands for this site. [37]
Only three PDB entries are available for the M6P-sens-
ing core of the receptor; namely of a domain 1–3 fragment, 
one unbound ligand (1Q25), [38] and two nearly identical 
structures with bound M6P (1SZ0 and 1SYO). [39] An ini-
tial VAST search of 1Q25 and 1SZ0 revealed few potential 
PSSC partners (three hits for each structure, see the Support-
ing Information). Therefore, MD simulations with 1000-ps in-
tervals were performed on domains 1–3 of both the ligand-un-
bound (1Q25) and ligand-bound (1SZ0) structures. In the for-
Figure 3. Top: Docked structure of Cdc25A (1C25) and dys-
idiolide. The highlighted residues are Cys 430, Glu 431, and 
Arg 436. Middle: Conformer 668, the midpoint conformer 
of the black-shaded cluster shown in Figure 2 (see also Ta-
ble 1 for evidence that MD samples particularly relevant con-
formational space for the Cdc25A/AChE/11HSD PSSC clus-
ter in this time regime). Bottom: Structural overlay (DaliLite) 
of conformer 668 of Cdc25A following MD simulation (blue) 
with acetylcholinesterase (1H22, red) and 11β-HSD1 (1XSE, 
green). VAST fi nds this triplet only after the initial 1C25 coor-
dinates are allowed to relax through MD.
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mer case, conformers were arbitrarily sampled at 100-ps in-
tervals and subjected directly to VAST searches. The 700-ps 
conformer identifi ed the interesting carbonic anhydrase (CA) 
from N. gonorrhoeae (1KOQ) [40] as a potential cluster part-
ner for this M6P receptor.
The ligand-bound conformers were clustered by domain 3, 
and VMD-extracted [41] 25-Å cores (centered on C5 of the 
M6P ligand) from midpoint conformers of the 10 most pop-
ulated clusters were subjected to VAST searches. From the 
fi fth cluster, a connection to epidermal fatty acid binding pro-
tein (E-FABP) emerged. E-FABP belongs to a family of lip-
id-binding proteins that are associated with fatty acid signal-
ing, cell growth, and cell differentiation. E-FABP is known to 
be overexpressed in hyperproliferative skin diseases, such as 
psoriasis, [42] and also appears to be a cancer marker. [43] 
For these reasons, this target appears to be an excellent PSS 
cluster partner for the M6P-IGF2R. Neither N. gonorrhoe-
ae, CA, nor E-FABP were identifi ed by VAST searches with-
out MD. An overlay of the ligand-bound receptor core (750-ps 
conformer) with E-FABP is presented in Figure 5. 
In conclusion, we describe a new clustering procedure for 
PSSC that exploits MD and the VAST algorithm. This stream-
lined approach removes serial structure retrieval and visual 
alignment steps previously required for clustering (Cdc25A 
PSSC), and opens up new windows to structural neighbors not 
seen when dealing with fi xed X-ray crystal structure coordi-
nates (M6P/IGF2R PSSC). Our results suggest that, in gener-
al, by treating otherwise static PDB entries as an ensemble of 
conformers generated by MD, one can sample a broader, and 
potentially more relevant, swath of protein-structure space 
when searching for structural partners.
References
  [1]  M. A. Koch, H. Waldmann, Drug Discovery Today 2005, 10, 
471. 
  [2]  M. A. Koch, L.-O. Wittenberg, S. Basu, D. A. Jeyaraj, E. Gour-
zoulidou, K. Reinecke, A. Odermatt, H. Waldmann, Proc. Natl. 
Acad. Sci. USA 2004, 101, 16721. 
  [3]  R. Breinbauer, I. R. Vetter, H. Waldmann, Angew. Chem. 2002, 
114, 3002;  Angew. Chem. Int. Ed. 2002, 41, 2878.  
  [4]  L. Holm, J. Park, Bioinformatics 2000, 16, 566.  
  [5]  J. Fejzo, C. A. Lepre, J. W. Peng, G. W. Bemis, Ajay, M. A. 
Murcko, J. M. Moore, Chem. Biol. 1999, 6, 755.  
  [6]  J.-F. Gibrat, T. Madej, S. H. Bryant, Curr. Opin. Struct. Biol. 
1996, 6, 377.  
  [7]  J.-Y. Ortholand, A. Ganesan, Curr. Opin. Chem. Biol. 2004, 8, 
271. 
  [8]  C. Lipinski, A. Hopkins, Nature 2004, 432, 855. 
  [9]  a) D. S. Tan, Nat. Chem. Biol. 2005, 1, 74; b) M. D. Burke, 
E. M. Berger, S. L. Schreiber, J. Am. Chem. Soc. 2004, 126, 
14095; c) M. D. Burke, S. L. Schreiber, Angew. Chem. 2004, 
116, 48;  Angew. Chem. Int. Ed. 2004, 43, 46.  
[10]  A. Noeren-Mueller, I. Reis-Correa, Jr., H. Prinz, C. Rosen-
baum, K. Saxena, H. J. Schwalbe, D. Vestweber, G. Cagna, S. 
Schunk, O. Schwarz, H. Schiewe, H. Waldmann, Proc. Natl. 
Acad. Sci. USA 2006, 103, 10606.  
[11]  a) A. M. Boldi, Curr. Opin. Chem. Biol. 2004, 8, 281;  b) D. J. 
Newman, G. M. Cragg, K. M. Snader, J. Nat. Prod. 2003, 66, 
1022;  c) M.-L. Lee, G. Schneider, J. Comb. Chem. 2001, 3, 
284.  
[12]  a) G. Klebe, Drug Discovery Today 2006, 11, 580;  b) N. Wes-
kamp, D. Kuhn, E. Huellermeier, G. Klebe, Bioinformatics 
2004, 20, 1522.  
[13]  A. Shulman-Peleg, R. Nussinov, H. J. Wolfson, J. Mol. Biol. 
2004, 339, 607.  
[14]  T. A. Binkowski, L. Adamian, J. Liang, J. Mol. Biol. 2003, 332, 
505.  
[15]  M. Stahl, C. Taroni, G. Schneider, F. Hoffmann, Protein Eng. 
2000, 13, 83.  
[16]  K. Kinoshita, J. i. Furui, H. Nakamura, J. Struct. Funct. Ge-
nomics 2002, 2, 9.  
[17]  A. Stark, S. Sunyaev, R. B. Russell, J. Mol. Biol. 2003, 326, 
1307.  
[18]  N. D. Gold, R. M. Jackson, J. Mol. Biol. 2006, 355, 1112.  
[19]  R. B. Russell, P. D. Sasieni, M. J. E. Sternberg, J. Mol. Biol. 
1998, 282, 903.  
[20]  B. M. McArdle, M. R. Campitelli, R. J. Quinn, J. Nat. Prod. 
2006, 69, 14.  
[21]  E. B. Fauman, J. P. Cogswell, B. Lovejoy, W. J. Rocque, W. 
Holmes, V. G. Montana, H. Piwnica-Worms, M. J. Rink, M. A. 
Figure 4. MD-assisted clustering procedure for the cation-in-
depedent mannose 6-phosphate/insulin-like growth factor II 
receptor. BP=binding protein.
Figure 5. Overlay of the MD-relaxed (750 ps) M6P-IGF2R 
core (blue) with the human E-FABP (green). The 1SZ0-bound 
M6P ligand (position at 750 ps) is highlighted with a ball-and-
stick model.
7770                                           CHARETTE ET AL. IN ANGEWANDTE CHEMIE INT. ED. 45 (2006)
Saper, Cell 1998, 93, 617.  
[22]  M. A. Lyon, A. P. Ducruet, P. Wipf, J. S. Lazo, Nat. Rev. Drug 
Discovery 2002, 1, 961.  
[23]  a) I. N. Shindyalov, P. E. Bourne, Nucleic Acids Res. 2001, 29, 
228;  b) I. N. Shindyalov, P. E. Bourne, Protein Eng. 1998, 11, 
739.  
[24]  L. Holm, C. Sander, Nucleic Acids Res. 1996, 24, 206.  
[25]  J. Zuegg, K. Gruber, M. Gugganig, U. G. Wagner, C. Kratky, 
Protein Sci. 1999, 8, 1990.  
[26]  U. Ermler, C. H. Hagemeier, A. Roth, U. Demmer, W. Gra-
barse, E. Warkentin, J. A. Vorholt, Structure 2002, 10, 1127.  
[27]  a) A. Andreeva, D. Howorth, S. E. Brenner, T. J. P. Hubbard, 
C. Chothia, A. G. Murzin, Nucleic Acids Res. 2004, 32, D 226; 
b) L. Lo Conte, S. E. Brenner, T. J. P. Hubbard, C. Chothia, A. 
G. Murzin, Nucleic Acids Res. 2002, 30, 264; c) A. G. Murzin, 
S. E. Brenner, T. Hubbard, C. Chothia, J. Mol. Biol. 1995, 247, 
536.  
[28]  S. P. Gunasekera, P. J. McCarthy, M. Kelly-Borges, E. Lob-
kovsky, J. Clardy, J. Am. Chem. Soc. 1996, 118, 8759.  
[29]  a) W. Sherman, T. Day, M. P. Jacobson, R. A. Friesner, R. Farid, 
J. Med. Chem. 2006, 49, 534;  b) C. A. Sotriffer, O. Kraemer, 
G. Klebe, Proteins Struct. Funct. Bioinf. 2004, 56, 52.  
[30]  D. S. Goodsell, A. J. Olson, Proteins Struct. Funct. Genet. 
1990, 8, 195.  
[31]  X. Daura, K. Gademann, B. Jaun, D. Seebach, W. F. VanGun-
steren, A. E. Mark, Angew. Chem. 1999, 111, 249;  Angew. 
Chem. Int. Ed. 1999, 38, 236.  
[32]  D. M. Wong, H. M. Greenblatt, H. Dvir, P. R. Carlier, Y.-F. 
Han, Y.-P. Pang, I. Silman, J. L. Sussman, J. Am. Chem. Soc. 
2003, 125, 363.  
[33]  D. Ogg, B. Elleby, C. Norstroem, K. Stefansson, L. Abrahm-
sen, U. Oppermann, S. Svensson, J. Biol. Chem. 2005, 280, 
3789.  
[34]  a) A. B. Hassan, Am. J. Pathol. 2003, 162, 3;  b) J. C. Byrd, J. 
H. Y. Park, B. S. Schaffer, F. Garmroudi, R. G. MacDonald, 
J. Biol. Chem. 2000, 275, 18647;  c) R. G. MacDonald, S. R. 
Pfeffer, L. Coussens, M. A. Tepper, C. M. Brocklebank, J. E. 
Mole, J. K. Anderson, E. Chen, M. P. Czech, A. Ullrich, Sci-
ence 1988, 239, 1134.  
[35]  a) J. Li, G. G. Sahagian, Oncogene 2004, 23, 9359;  b) D. B. 
O’Gorman, J. Weiss, A. Hettiaratchi, S. M. Firth, C. D. Scott, 
Endocrinology 2002, 143, 4287;  c) G. R. Hankins, A. T. De 
Souza, R. C. Bentley, M. R. Patel, J. R. Marks, J. D. Iglehart, 
R. L. Jirtle, Oncogene 1996, 12, 2003.  
[36]  S. J. York, L. S. Arneson, W. T. Gregory, N. M. Dahms, S. Ko-
rnfeld, J. Biol. Chem. 1999, 274, 1164.  
[37]  D. B. Berkowitz, G. Maiti, B. D. Charette, C. D. Dreis, R. G. 
MacDonald, Org. Lett. 2004, 6, 4921.  
[38]  L. J. Olson, R. D. Yammani, N. M. Dahms, J.-J. P. Kim, EMBO 
J. 2004, 23, 2019.  
[39]  L. J. Olson, N. M. Dahms, J.-J. P. Kim, J. Biol. Chem. 2004, 
279, 34000.  
[40]  S. Huang, Y. Xue, E. Sauer-Eriksson, L. Chirica, S. Lindskog, 
B.-H. Jonsson, J. Mol. Biol. 1998, 283, 301.  
[41]  W. Humphrey, A. Dalke, K. Schulten, J. Mol. Graphics 1996, 
14, 33.  
[42]  G. Siegenthaler, R. Hotz, D. Chatellard-Gruaz, S. Jaconi, J. H. 
Saurat, Biochem. Biophys. Res. Commun. 1993, 190, 482.  
[43]  a) L. H. Gutierrez-Gonzalez, C. Ludwig, C. Hohoff, M. Radem-
acher, T. Hanhoff, H. Ruterjans, F. Spener, C. Lucke, Biochem. 
J. 2002, 364, 725;  b) P. Sinha, G. Hutter, E. Kottgen, M. Di-
etel, D. Schadendorf, H. Lage, Electrophoresis 1999, 20, 2952. 
Supporting information for this article follows:
 S1
Protein Structure Similarity Clusters (PSSC): Dynamic Treatment of PDB Structures 
Facilitates Clustering 
 
Bradley D. Charette, Richard G. MacDonald, Stefan Wetzel, David B. Berkowitz*, and 
Herbert Waldmann*  
 
 
 
 
 
PART I – ORIGINAL CLUSTER .................................................................................................................... 2 
ORIGINAL DYSIDIOLIDE INSPIRED LIBRARY:................................................................................................... 2 
DYSIDIOLIDE DOCKING:.................................................................................................................................... 3 
MOLECULAR DYNAMICS:.................................................................................................................................. 5 
CLUSTERING: ..................................................................................................................................................... 7 
STRUCTURE ALIGNMENTS: ............................................................................................................................... 9 
PART II – M6P/IGF2R BASED CLUSTER................................................................................................. 11 
MD SIMULATIONS ON THE M6P/IGF2 RECEPTOR:....................................................................................... 11 
CLUSTERING, CORE EXTRACTION, & STRUCTURE ALIGNMENTS:................................................................ 13 
M6P/IGF2R CENTERED CLUSTER: ................................................................................................................ 14 
 
 S2
 
Part I – Original Cluster 
Original Dysidiolide-Inspired Library: 
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scaf f old
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OH
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Cdc25A - 9.4 µM
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O
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1
Cdc25A 0.35 µM
AChE >20 µM
11?HSDH-1 14 µM
11?HSDH-2 2.4 µM
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O
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O
3
Cdc25A 45 µM
AChE >20 µM
11?HSDH-1 10 µM
11?HSDH-2 95 µM
Cdc25A 1.8 µM
AChE >20 µM
11?HSDH-1 19 µM
11?HSDH-2 6.7 µM
O
O
2OH
 
Figure S1  Original dysidiolide-inspired library including inhibition data for Cdc25A, AChE, 
11?HSDH-1, and 11?HSDH-2. 
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Dysidiolide Docking:  The atomic coordinates for Cdc25A were taken from 1C25[1], the only 
available Cdc25a crystal structure.  This structure represents the catalytically active fragment 
of Cdc25a.  The crystal structure was prepared for docking and eventual molecular dynamics 
simulation by repairing missing atoms from sidechains: K470, K356, K396, and K377, using 
Tripos Sybyl.  For docking, polar hydrogens and partial charges were added using Autodock 
Tools.   
 
Dysidiolide (Fig. S1) was prepared for docking using Accelrys Materials Studio for building, 
minimizing, and assignment of partial charges.  Dysidiolide was further processed using 
Autodock Tools to merge non-polar hydrogens and assign rotable bonds.       
 
For docking, an 80x80x80 point gridmap (0.375 angstrom spacing) centered on the active site 
sulfur of C430, was generated with Autodock 3.0.  100 docking runs (genetic algorithm/local 
search, 250,000 max energy evals/run) were performed with Autodock 3.0 and the best 
scoring docked conformer of dysidiolide was chosen as the starting conformer for a 
molecular dynamics simulation.  
Figure S2  (-)-Dysidiolide docked to the active site of Cdc25A. 
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Binding 
affinity 
(kcal/mol) 
Docking 
affinity 
(kcal/mol) 
1 -7.23 -9.69 
2 -6.77 -8.99 
3 -5.27 -7.91 
4 -6.13 -7.59 
5 -4.95 -6.84 
Figure S3  (-)-Dysidiolide docked to Cdc25A catalytic core, with key active site residues (C430, E431, 
and R436) visible. 
Figure S4 Top-scoring cluster of docking results (based on Autodock predicted binding affinity, left).  
Autodock predicted binding and docking affinities for members of the docked cluster (right).   
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Molecular Dynamics:  A dysidiolide 
topology was generated using ProDRG[2] 
and the Gromos 96.1 force field.  
Cdc25A was then solvated in a virtual 
water box containing 12,920 water 
molecules.  A net charge of -2 was 
neutralized by replacing two water 
molecules with 2 sodium ions.  Next, a 
500 step, steepest decent energy 
minimization was performed on the 
system using Gromacs 3.3.[3]  The system 
was then subjected to a 20 picosecond 
position-restrained “soaking” molecular 
dynamics simulation.  During this 
simulation, the positions of the Cdc25A 
and dysidiolide atoms were restrained, 
while allowing water molecules to relax 
freely.  After the above mentioned 
“soaking”, the entire system was subjected to an unrestrained molecular dynamics simulation 
for 1 nanosecond.  The trajectory was recorded at one picosecond time points for subsequent 
analysis.     
Figure S5  Solvated Cdc25A. 
Figure S6  Overlay of conformers taken at 100 picosecond timepoints during the Cdc25A MD 
simulation.  Color scales with time from red (0 ps/Start), to green (Middle), to blue (1 ns/End).    
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Figure S7  RMSD change in Cdc25A’s C? backbone over time (after least squares alignments). 
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Figure S8  RMSD change in dysidiolide atom positions over time (after least squares alignments). 
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Clustering:  Conformational clustering was performed on the molecular dynamics trajectory 
of Cdc25A in order to intelligently select representative conformations for use in structure 
alignment searches.  Clustering was performed using C? backbone atoms, least squares 
alignment, and the Gromos algorithm[4] (cutoff: 0.75 Å) as implemented by Gromacs 3.3.  
This method creates clusters so that the midpoint conformation of a given cluster is within a 
0.75 Å C? RMSD of any member in that cluster.  The 0.75 Å cutoff distance was arrived at 
by an iterative process.  Clustering with cutoffs of 1.0 and 0.5 Å were also examined, but 
gave either too few (heavily populated), or too many (lightly populated) clusters, 
respectively.  Midpoint conformations of the top 10 most populated clusters were saved for 
further use in structure alignment searches.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure S9  Chart displaying cluster population vs midpoint after clustering with the Gromos 
algorithm and a 0.75 Å cutoff.  Sixty total clusters were generated.  Highlighted in red is the 7th 
most populated cluster which has a midpoint conformation occurring at 668 picoseconds into the 
simulation.  This conformation provided the best alignment to AChE and 11?-HSD, upon 
submission to VAST. 
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Cluster 1 2 3 
Population 102 84 84 
Midpoint 872 735 511 
818    820    821    822    823    824    825 697    698    699    701    704    705    707 471    475    477    479    482    485    486 
826    827    828    837    839    840    841 709    711    712    713    714    715    716 490    492    495    496    497    500    501 
851    852    853    854    855    856    857 717    718    719    720    721    722    723 502    503    504    505    506    507    508 
858    861    862    863    864    865    866 724    725    726    727    728    729    730 509    510    511    512    513    514    515 
867    868    869    870    871    872    873 731    732    733    734    735    736    737 516    517    518    519    520    521    522 
874    875    876    877    878    879    880 738    739    740    741    742    743    744 523    524    525    526    527    528    529 
881    882    885    886    887    888    889 745    746    747    748    752    753    754 530    535    536    537    538    540    541 
890    891    892    893    894    895    897 755    756    757    758    759    760    761 542    543    544    545    546    550    556 
899    900    902    903    904    907    908 762    763    764    765    766    767    768 557    558    559    560    561    562    563 
909    910    911    912    913    915    916 769    770    771    772    773    774    775 564    565    566    567    568    569    570 
917    918    919    920    921    925    927 776    777    778    779    780    781    782 571    572    573    574    575    576    577 
928    929    930    931    932    933    934 785    786    787    790    795    797    838 578    579    580    586    592    593    594 
938    942    943    948    949    958    962    
966    967    968    974    975    976    977    
Member 
Conformers 
979    980    981    986    
Cluster 4 5 6 
Population 58 54 54 
Midpoint  354 303 415 
326    327    328    329    332    337    338 234    240    260    261    263    264    268 375    376    377    380    381    401    402 
339    340    341    342    343    344    345 275    277    278    279    280    281    282 403    405    406    408    409    410    411 
346    347    348    349    350    351    352 283    284    285    286    287    288    289 412    413    414    415    416    417    418 
353    354    355    356    357    358    359 290    291    292    293    294    295    296 419    420    421    422    423    424    425 
360    361    362    363    364    365    366 297    298    299    300    301    302    303 426    427    428    429    430    431    432 
367    368    369    370    371    372    373 304    305    306    307    308    309    310 433    434    435    436    438    439    440 
374    378    382    383    385    386    387 311    312    316    317    318    319    320 442    445    446    447    449    450    451 
389    390    391    392    393    394    395 321    322    323    324    325 452    453    454    455    456 
396    397    
Member 
Conformers 
 
  
    
Cluster 7 8 9 
Population 52 39 37 
Midpoint  668 610 212 
640    642    647    648    651    652    653 591    596    597    598    600    601    602 193    194    196    197    198    199    201 
654    655    658    659    660    661    663 603    604    605    606    607    608    609 202    203    205    206    207    208    209 
664    665    666    667    668    669    670 610    611    612    613    614    615    616 210    211    212    213    214    215    216 
671    672    673    674    675    676    677 617    618    619    620    621    622    623 217    218    219    220    221    223    224 
678    679    681    686    688    689    690 624    625    626    627    628    629    630 225    226    227    228    229    230    231 
691    692    693    694    695    696    700 631    632    633    634 232    233 
702    703    706    708    710    794    796    
798    799    805    
Member 
Conformers 
 
  
    
Cluster 10     
Population 37     
Midpoint  978     
898    901    922    923    926    937    941    
944    952    953    954    955    956    957    
959    960    961    963    964    969    970    
971    972    973    978    982    983    984    
985    987    988    989    990    994    995    
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998   1000     
 
Figure S10  Members of the top 10 most populated conformation clusters for Cdc25A.  The numbers given in the 
Member Conformers box correspond to the picosecond timepoints in the simulation at which given conformers 
were recorded.   
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Structure Alignments:  Midpoint conformations from each cluster, along with conformers 
taken at 100 ps timepoints throughout the simulation, were submitted to the Vector 
Alignment Search Tool (VAST)[5] available on NCBI’s website.  Results from each search 
were then screened for matches against 11? hydroxysteroid dehydrogenase, types 1 & 2 
(11?HSD), acetylcholine esterase (AChE), tropinone reductase, hydroxynitrile lyase, and 
methylene-tetrahydromethanopterin dehydrogenase (MTHMP DH).  In addition to VAST 
alignments, Cdc25A was aligned to AChE and 11?HSD structures at 100 ps intervals using 
DaliLite.[6] 
 
 
The midpoint conformer of cluster 7, which occurs at 668 picoseconds, matches 14 of 66 
acetylcholine esterase structures and 1 of 6 11? hydroxysteroid dehydrogenase structures in 
the PDB.  Since this conformer was the only conformer tested that provided VAST hits 
against 11? hydroxysteroid dehydrogenase, a closer look was given to the residues 
responsible for the overlay.  Figure S12 displays a plot of the RMSD change over time in the 
aligned portion of conformation 668.  During the period from 600 to 700 picoseconds in the 
simulation, these residues appear to undergo a sharp change in alignment and it is suspected 
that this movement may be responsible for the success of conformation 668 in aligning with 
Structure submitted for 
Alignment 
VAST Structure Alignment Results 
    
    
AChE   11?-HSD Trop 
Red. 
OH Nitrile 
Lyase 
MTHMP 
DH 
  Members 
Midpoint 
(ps) 
66 6  6 23 2 
Cluster 1 102 872       22 2 
Cluster 2 84 735       5   
Cluster 3 84 511       12   
Cluster 4 58 354       20 1 
Cluster 5 54 303       17   
Cluster 6 54 415       1   
Cluster 7 52 668 14 1 3 22 2 
Cluster 8 39 610       22 2 
Cluster 9 37 212       2   
Cluster 10 37 978       2   
0 ps               
100 ps          17   
200 ps           1   
300 ps          20 2 
400 ps           18   
500 ps          22 2 
600 ps           20 2 
700 ps    1   2 21 2 
800 ps     1     22 2 
900 ps          22 2 
1000 ps           17 2 
Figure S11  Results of VAST structure alignments for selected conformers.  Results are listed as 
the number of matches against acetylcholine esterase, 11? hydroxysteroid dehydrogenase, hydroxy 
nitrile lyase, and methylene-tetrahydromethanopterin dehydrogenase.  The total number of  PDB-
deposited structures for each protein is listed in blue.  The conformer at 668 ps, the midpoint of 
cluster 7, provided the most matches, and is highlighted in red.   
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11?HSD.  A similar plot (Figure S13), tracks the RMSD change in regions of 668 which 
align with AChE (structure:1H22).  This plot provides no apparent explanation the 
conformers at 668, 700, or 800 ps aligning to acetylcholine esterase.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S12  RMSD, over time, of the C? backbone of Cdc25A which align to 11? hydroxysteroid 
dehydrodgenase (1XSE). 
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Figure S13  RMSD, over time, of the Cdc25A’s C? backbone which aligns to acetylcholine 
esterase (1H22). 
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Part II – M6P/IGF2R Based Cluster 
MD Simulations on the M6P/IGF2 Receptor:  Since there are both ligand bound (1SZ0[7]) 
and ligand unbound (1Q25[8]) crystal structures available for the N-terminal three domain 
construct of the M6P/IGF2R, both were chosen for molecular dynamics simulations.  Chain 
B was chosen from 1SZ0, as it exhibited fewer missing residues than chain A.  Missing atoms 
and residues from 1SZ0 chain B and 1Q25 were repaired using Tripos Sybyl.  Using the 
coordinates of mannose 6-phosphate from the 1SZ0 crystal structure, a Gromos 96.1 force 
field topology was generated using ProDRG.   
 
The procedure for the molecular dynamics simulations on ligand bound and unbound 
M6P/IGF2 receptor were identical to that for Cdc25A.  Structures were first solvated, net 
charge neutralized, then energy minimized by 500 step steepest decent method, soaked during 
20 ps of position restrained molecular dynamics, then subjected to an unrestrained molecular 
dynamics simulation for 1 nanosecond, all using the Gromacs 3.3 software package.     
 
 
As seen in Figure S14, domain 3 of the M6P/IGF2R appears to be the primary site of M6P 
interaction with the N-terminal 3 domain construct.  Based on this, the C? RMSD of domain 
Figure S14  Crystal structure of the N-terminal 3 domains of the M6P/IGF2R bound to mannose 6-
phosphate (1SZ0 chain B).  Domain 3 (green) forms a binding site for mannose 6-phosphate.  Domains 
1 (blue) and 2 (red) have also been described as necessary for formation of a high-affinity pocket.       
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3 residues was tracked over the course of both ligand bound and unbound simulations.  Plots 
of these changes can be seen in Figures S15 and S16. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S15  Plot of the change over time in C-alpha RMSD (after least squares alignments) for 
domain 3 residues of the M6P/IGF2R ligand bound molecular dynamics simulation. 
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Figure S16  Plot of the change over time in C-alpha RMSD (after least squares alignments) for 
domain 3 residues of the M6P/IGF2R ligand free molecular dynamics simulation. 
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Clustering, Core Extraction, & Structure Alignments:  The N-terminal 3 domains of the 
M6P/IGF2R have few initial matches in structure alignment searches.  This could be due to 
the limited number of membrane-bound receptor crystal structures in the PDB.  In fact, 
VAST searches on domain 3 of the ligand free structure (1Q25) result in only 3 alignments 
from VAST’s low redundancy data set.  The aligned proteins comprise: N9 Tern Influenza 
Neuraminidase (1XOG), Metallo ?-Lactamase II (2BC2), and Flavoprotein TM0755 from 
Thermotoga maritima (1VME).  A search on domain 3 of the ligand bound structure (1SZ0 
chain B) yields 3 results, as well.  These are: Lectin-1 from Trichosanthes kirilowii (1GGP), 
Polyadenylate Polymerase from Vaccinia Virus (2GA9), and Flavoprotein TM0755 from 
Thermotoga maritima (1VME).   
  
Representatives are chosen for the low redundancy subset based on BLAST p values of 10-7 
relative to other members contained in a representative group.  Counting structural neighbors 
from just this subset streamlines the process of filtering out multiple hits from identical or 
nearly identical proteins.  With this in mind, conformations taken at 100 ps intervals from 
each MD simulation were submitted to VAST to see if MD simulation could expand the 
range of structural neighbors.     
   
 
  Ligand Free   Ligand Bound 
  
Structure 
L.R. 
VAST 
Hits   
Structure 
L.R. 
VAST 
Hits 
Native 
Structure 
1Q25 3   1SZ0 B 3 
100 ps 2   100 ps  8 
200 ps 7   200 ps 11 
300 ps 14   300 ps  8 
400 ps 8   400 ps  2 
500 ps 8   500 ps  8 
600 ps 3   600 ps  8 
700 ps 4   700 ps  5 
800 ps 4   800 ps  6 
900 ps 16   900 ps  10 
MD 
Generated 
Conformers 
1000 ps 1   1000 ps  3 
  
From this initial search, it can be seen that taking conformers from multiple time points in the 
simulation dramatically improves the number of VAST-identified structural neighbors. 
 
To provide a more focused search for structural neighbors of the M6P binding pocket, 
binding cores were extracted from conformers generated during the ligand bound 
M6P/IGF2R simulation.  First, clusters were generated using only C? coordinates from 
domain 3 residues and the Gromos algorithm as implemented by Gromacs 3.3.  This 
clustering method was chosen to provide the best chance of identifying the most unique 
conformations of domain 3, independent of any changes in domains 1 and 2 which might bias 
the clustering procedure.  Then, a 25Å core was extracted from the midpoint conformation of 
Figure S17  Results of VAST searches on conformers from both 
ligand bound and ligand free simulations.  Results are listed as the 
number of structural neighbors (to domain 3) identified in VASTs 
low redundency data set.   
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each of the 10 most populated clusters.  This was achieved by cutting out a 25 Å sphere, 
centered on the C5 ring carbon of M6P,  using Visual Molecular Dynamics (VMD)[9].  These 
25 Å cores were then subjected to VAST searches.    
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
M6P/IGF2R Centered Cluster: After analyzing VAST search results from various arbitrary 
(100 ps time point) conformations, refined by extraction of 25 Å cores, a potential PSSC 
cluster of M6P/IGF2R, carbonic anydrase (coordinates: 1KOQ[10]), and epidermal fatty acid 
binding protein (E-FABP, coordinates: 1JJJ[11]) was identified.    
Figure S19  VAST aligned backbones for the 25 Å cluster 5 core aligned with E-FABP/1JJJ 
(left) and the ligand unbound 700 ps conformer aligned with carbonic anhydrase/1KOQ (right). 
Figure S18  Clusters resulting from domain 3-based clustering are depicted in blue.  
Clustering based on domains 1-3 are colored in red.  The most frequently sampled 
conformation of domain 3 (cluster 1 midpoint: 531 ps) would not be apparent if all 3 domains 
were used for clustering.     
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Search Structure Match 
Aligned 
Length 
RMSD 
VAST 
Score 
p value 
%Sequence 
ID 
Ligand Free                         
700 ps conformer 
1KOQ  70 2.9 10.9 0.0187 2.9 
Ligand Bound - cluster 5 
midpoint - 25 angstrom 
core 
1JJJ  44 3.2 8.3 0.0313 6.8 
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Figure S20  VAST statistics for M6P/IGF2R alignments with carbonic anhydrase (coordinates: 1KOQ) 
and epidermal fatty acid binding protein (coordinates:1JJJ). 
